Branched multipeptide immunotherapy for glioblastoma using human leukocyte antigen-A*0201-restricted cytotoxic T-lymphocyte epitopes from ERBB2, BIRC5 and CD99

Ítems similars

• IMPS-17 BRANCHED-MULTIPEPTIDE IMMUNOTHERAPY FOR GLIOBLASTOMA USING HLA-A*0201-RESTRICTED CYTOTOXIC T-LYMPHOCYTE EPITOPE FROM BIRC5, CD99 AND ERBB2
  per: Jung, Tae-Young, et al.
  Publicat: (2015)
• Peptide Vaccine Combined Adjuvants Modulate Anti-tumor Effects of Radiation in Glioblastoma Mouse Model
  per: Tran, Thi-Anh-Thuy, et al.
  Publicat: (2020)
• Feasibility of dendritic cell-based vaccine against glioblastoma by using cytoplasmic transduction peptide (CTP)-fused protein antigens combined with anti-PD1
  per: Kim, Young-Hee, et al.
  Publicat: (2020)
• The Clinical Usefulness of (99m)Tc HMPAO Leukocyte/(99m)Tc Phytate Bone Marrow Scintigraphy for Diagnosis of Prosthetic Knee Infection: A Preliminary Study
  per: Jung, Kyung Pyo, et al.
  Publicat: (2012)
• Betacellulin-Induced Beta Cell Proliferation and Regeneration Is Mediated by Activation of ErbB-1 and ErbB-2 Receptors
  per: Oh, Yoon Sin, et al.
  Publicat: (2011)